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Volume xx, Number x Abstracts 1245Kaplan–Meier life tables. Univariate and multivariate analyses were used to
assess the influence of various risk factors on primary patency.
Results: Complete data were obtained from 60 patients who under-
went 61 single-step hybrid procedures. Technical and haemodynamic suc-
cess rates were 100% and 95%, respectively. The perioperative mortality rate
was 3%. The primary and assisted-primary patency rates at 12 months were
71% and 98%, respectively. Primary patency rates were lower in group 3
when compared with groups 1 and 2 (log-rank test, p  0.006). The
presence of diabetes and dyslipidaemia were independent predictors of
decreased primary patency (p  0.003 and p  0.014, respectively).
Conclusions: Hybrid procedures provide an effective treatment man-
agement of selected patients with multilevel lower extremity arterial disease.
The extent of the disease, diabetes and dyslipidaemia are associated with
worse outcome.
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Diabetes mellitus (DM) is an independent predictor for morbidity and
mortality in the general population, which is even more apparent in patients
with concomitant cardiovascular risk factors. As the prevalence of DM is
increasing, with an ageing general population, it is expected that the number
of diabetic patients requiring surgical interventions will increase. Periopera-
tive hyperglycaemia, without known DM, has been identified as a predictor
for morbidity and mortality in patients undergoing surgery. Moreover, early
studies showed that intensive blood-glucose-lowering therapy reduced both
morbidity and mortality among patients admitted to the postoperative
intensive care unit (ICU). However, later studies have doubted the benefit
of intensive glucose control in medical–surgical ICU patients. This article
aims to comprehensively review the evidence on the use of perioperative
intensive glucose control, and to provide recommendations for current
clinical practice. A systematic review was performed of the literature on
perioperative intensive glucose control. Based on this literature review, we
observed that intensive glucose control in the perioperative period has noReaders can access EJVES articles at http://intl.eexternal validity of some studies are important barriers for widespread
recommendation of intensive glucose control in the perioperative setting.
We propose that guidelines recommending intensive glucose control should
be re-evaluated. In addition, moderate tight glucose control should cur-
rently be regarded as the safest and most efficient approach to patients
undergoing major vascular surgery.
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Objectives: Ultrasound guided foam sclerotherapy (UGFS) is a mini-
mally invasive treatment for varicose veins (VV) whose clinical and cost-
effectiveness remains incompletely defined. The aim of the current study was
to examine patients’ expectations before and satisfaction after UGFS for VV
in terms of relief of lower limb symptoms, improvement in appearance, and
beneficial effect on life-style.
Methods: A consecutive series of 351 patients (464 limbs) undergoing
UGFS for VV completed questionnaires one week prior to and six months
after treatment.
Results: Pre and post-treatment response rates were 80%; 60% re-
turned both questionnaires. Virtually all patients were expecting improve-
ment in lower limb symptoms; these were exceeded in a third. Most patients
expected cosmetic improvement and these were largely met. Two-thirds of
patients expected significant life-style (clothes, work, social) benefits and
outcomes were slightly less than expected. A quarter expected improvement
in their interpersonal relationships. This benefit was greater than expected
occurring in one-third of patients. Overall, a quarter of patients had their
expectations exceeded and 10% (appearance and relationships) to 25%
(clothing, work and social and leisure activities) were left with unmet
expectations.
Discussion: When specifically asked most patients admit to having a
wide range of expectations in relation to their VV treatment, many of them
probably unanticipated by the clinician. However, present data indicate that
UGFS is usually able to meet, and often exceeds, these physical and psycho-clear benefit on short-term mortality. Intensive glucose control may even
have a net harmful effect in selected patients. In addition, concerns on the
social needs and expectations. UGFS is, therefore, a highly effective treat-
ment for VV from the patients’ perspective.lsevierhealth.com/journals/ejvs/default.cfm
